MTA1 and breast cancer: mTOR is a signaling molecule involved in glucose metabolism and a therapeutic target for renal cell carcinoma and breast cancer.[21] Indeed, pharmacological validation revealed that MTA1‐KO cells were more sensitive to AZD8055, temsirolimus, zotarolimus, and torin1 (Figure 6D).